BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11457883)

  • 1. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice.
    Vaisman BL; Lambert G; Amar M; Joyce C; Ito T; Shamburek RD; Cain WJ; Fruchart-Najib J; Neufeld ED; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Clin Invest; 2001 Jul; 108(2):303-9. PubMed ID: 11457883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice.
    Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis.
    Joyce CW; Wagner EM; Basso F; Amar MJ; Freeman LA; Shamburek RD; Knapper CL; Syed J; Wu J; Vaisman BL; Fruchart-Najib J; Billings EM; Paigen B; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2006 Nov; 281(44):33053-65. PubMed ID: 16928680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes.
    Sahoo D; Trischuk TC; Chan T; Drover VA; Ho S; Chimini G; Agellon LB; Agnihotri R; Francis GA; Lehner R
    J Lipid Res; 2004 Jun; 45(6):1122-31. PubMed ID: 14993246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice.
    Singaraja RR; Stahmer B; Brundert M; Merkel M; Heeren J; Bissada N; Kang M; Timmins JM; Ramakrishnan R; Parks JS; Hayden MR; Rinninger F
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1821-7. PubMed ID: 16728652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
    Post SM; Groenendijk M; van der Hoogt CC; Fievet C; Luc G; Hoekstra M; Princen HM; Staels B; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2724-30. PubMed ID: 17008588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1.
    Cavelier C; Lorenzi I; Rohrer L; von Eckardstein A
    Biochim Biophys Acta; 2006 Jul; 1761(7):655-66. PubMed ID: 16798073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced hepatic apoA-I secretion and peripheral efflux of cholesterol and phospholipid in CD36 null mice.
    Yue P; Chen Z; Nassir F; Bernal-Mizrachi C; Finck B; Azhar S; Abumrad NA
    PLoS One; 2010 Mar; 5(3):e9906. PubMed ID: 20360851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations.
    Basso F; Freeman L; Knapper CL; Remaley A; Stonik J; Neufeld EB; Tansey T; Amar MJ; Fruchart-Najib J; Duverger N; Santamarina-Fojo S; Brewer HB
    J Lipid Res; 2003 Feb; 44(2):296-302. PubMed ID: 12576511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
    Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
    J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression.
    Thorngate FE; Yancey PG; Kellner-Weibel G; Rudel LL; Rothblat GH; Williams DL
    J Lipid Res; 2003 Dec; 44(12):2331-8. PubMed ID: 12951361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ABCA1 activity protects against atherosclerosis.
    Singaraja RR; Fievet C; Castro G; James ER; Hennuyer N; Clee SM; Bissada N; Choy JC; Fruchart JC; McManus BM; Staels B; Hayden MR
    J Clin Invest; 2002 Jul; 110(1):35-42. PubMed ID: 12093886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATP-binding cassette transporter AI and its role in HDL formation.
    Lee JY; Parks JS
    Curr Opin Lipidol; 2005 Feb; 16(1):19-25. PubMed ID: 15650559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity.
    Nandi S; Ma L; Denis M; Karwatsky J; Li Z; Jiang XC; Zha X
    J Lipid Res; 2009 Mar; 50(3):456-466. PubMed ID: 18941142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CETP expression enhances liver HDL-cholesteryl ester uptake but does not alter VLDL and biliary lipid secretion.
    Harada LM; Amigo L; Cazita PM; Salerno AG; Rigotti AA; Quintão EC; Oliveira HC
    Atherosclerosis; 2007 Apr; 191(2):313-8. PubMed ID: 16806230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
    Oku H; Matsuura F; Koseki M; Sandoval JC; Yuasa-Kawase M; Tsubakio-Yamamoto K; Masuda D; Maeda N; Ohama T; Ishigami M; Nishida M; Hirano K; Kihara S; Hori M; Shimomura I; Yamashita S
    FEBS Lett; 2007 Oct; 581(26):5029-33. PubMed ID: 17936760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers.
    Zheng H; Kiss RS; Franklin V; Wang MD; Haidar B; Marcel YL
    J Biol Chem; 2005 Jun; 280(22):21612-21. PubMed ID: 15797865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
    Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic ABCA1 and VLDL triglyceride production.
    Liu M; Chung S; Shelness GS; Parks JS
    Biochim Biophys Acta; 2012 May; 1821(5):770-7. PubMed ID: 22001232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced biliary sterol output with no change in total faecal excretion in mice expressing a human apolipoprotein A-I variant.
    Parolini C; Caligari S; Gilio D; Manzini S; Busnelli M; Montagnani M; Locatelli M; Diani E; Giavarini F; Caruso D; Roda E; Roda A; Sirtori CR; Chiesa G
    Liver Int; 2012 Oct; 32(9):1363-71. PubMed ID: 22845860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.